https://www.nxtpsychedelics.com/news/articles/psychedelics/enveric-biosciences-receives-notice-of-allowance-from-uspto-for-c4-carboxylic-acid-substituted-tryptamine-derivatives-for-next-generation-psilocin-prodrug/